Mark A. Weinberger's most recent trade in Metlife Inc was a trade of 562 Common Stock done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 562 | 16,907 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 1,316 | 10,737 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 540 | 16,345 (0%) | 0% | 0 | Common Stock | |
| JPMC | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 262.12 per share. | 21 Jan 2025 | 1,011 | 3,142 (0%) | 0% | 262.1 | 265,000 | Common Stock |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 535 | 15,805 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Mark A. Weinberger | Director | Purchase of securities on an exchange or from another person at price $ 147.22 per share. | 12 Dec 2024 | 1,000 | 1,000 (0%) | 0% | 147.2 | 147,220 | Common Stock |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 535 | 15,270 (0%) | 0% | 0 | Common Stock | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 627 | 14,735 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 1,385 | 9,129 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 594 | 14,108 (0%) | 0% | 0 | Common Stock | |
| JPMC | Weinberger Mark A. | Director | Grant, award, or other acquisition of securities at price $ 166.25 per share. | 16 Jan 2024 | 1,594 | 2,094 (0%) | 0% | 166.2 | 265,000 | Common Stock |
| MetLife | Weinberger A. Mark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 650 | 13,514 (0%) | 0% | 0 | Common Stock | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 710 | 12,864 (0%) | 0% | 0 | Common Stock | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 803 | 12,154 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 1,193 | 7,515 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 755 | 11,351 (0%) | 0% | 0 | Common Stock | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 31 | 10,596 (0%) | 0% | 0 | Common Stock | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 520 | 10,565 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2022 | 241 | 6,276 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 62.62 per share. | 03 Oct 2022 | 599 | 10,045 (0%) | 0% | 62.6 | 37,509 | Common Stock |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 260 | 6,035 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 62.53 per share. | 21 Jun 2022 | 600 | 9,446 (0%) | 0% | 62.5 | 37,518 | Common Stock |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 239 | 5,774 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 70.50 per share. | 01 Apr 2022 | 532 | 8,846 (0%) | 0% | 70.5 | 37,506 | Common Stock |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2022 | 245 | 5,534 | - | - | Deferred Share Units | |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,175 | 5,288 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 63.23 per share. | 03 Jan 2022 | 594 | 8,314 (0%) | 0% | 63.2 | 37,559 | Common Stock |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 242 | 4,113 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 62.52 per share. | 01 Oct 2021 | 600 | 7,720 (0%) | 0% | 62.5 | 37,512 | Common Stock |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2021 | 222 | 3,871 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 63.77 per share. | 15 Jun 2021 | 589 | 7,120 (0%) | 0% | 63.8 | 37,561 | Common Stock |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 226 | 3,648 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 61.60 per share. | 01 Apr 2021 | 609 | 6,531 (0%) | 0% | 61.6 | 37,514 | Common Stock |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2021 | 210 | 3,422 | - | - | Deferred Share Units | |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 1,123 | 3,211 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 46.08 per share. | 04 Jan 2021 | 814 | 5,922 (0%) | 0% | 46.1 | 37,509 | Common Stock |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 213 | 2,088 | - | - | Deferred Share Units | |
| MetLife | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 37.26 per share. | 01 Oct 2020 | 1,007 | 5,108 (0%) | 0% | 37.3 | 37,521 | Common Stock |
| Johnson & Johnson | Mark A. Weinberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2020 | 212 | 1,875 | - | - | Deferred Share Units |